（Reminder）Lecture: Key Considerations in Early Druggability Evaluation of Chemical Drugs 【Speaker：Dr. Ming Li, CEO of ZSHK Laboratories Limited, 02 June 2023, N22-G002】
（活動提醒）講座：化學藥物早期成藥性評價的關鍵因素【主講人：李明博士，滬港中科國際生物科技有限公司CEO ，2023年06月02日，N22-G002】
藥物研發面臨的主要挑戰之一是由於患者選擇不足或缺乏可靠的生物標誌物或治療效益指標而導致許多臨床試驗失敗。本次講座將探討如何解决這些挑戰，提高藥物開發的成功率。
One of the primary challenges faced in drug R&D is the failure of many clinical trials due to inadequate patient selection or the lack of reliable biomarkers or indicators for therapeutic benefits. This lecture will address these challenges and improve the success rate of drug development.
|
日期 Date: |
02 June 2023 (Friday) |
|
時間 Time: |
3:00 – 5:00 p.m. |
|
地點 Venue: |
N22-G002 |
|
題目 Title: |
化學藥物早期成藥性評價的關鍵因素 Key Considerations in Early Druggability Evaluation of Chemical Drugs |
|
主講人 Speaker: |
李明博士，滬港中科國際生物科技有限公司CEO Dr. Ming Li, CEO of ZSHK Laboratories Limited |
|
語言 Language: |
普通話 Mandarin |
|
對象 Audience: |
All staff and students are welcome |
|
報名 Registration: |
